Clinical Trial Update: Cost Comparison Study of Darbepoetin Versus Epoetin Therapy to Treat Anemia in Hemodialysis Patients [Phase 4]

View source ↗

Summary

A Phase 4 cost comparison trial comparing darbepoetin and epoetin for anemia in hemodialysis patients has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• Darbepoetin (darbepoetin alfa)
• epoetin (epoetin)

Snippet

Sponsor: Andrea L Woodland | Conditions: Anemia, Chronic Kidney Disease | Phase 4 | Status: COMPLETED | Results posted: 2019-09-10